Novo Nordisk Releases Higher-Dose Wegovy in U.S.

Novo Nordisk has launched a higher-dose version of its weight-loss drug Wegovy, known as Wegovy HD, in the United States. This new formulation offers the highest dosage of the medication available to date, aiming to provide enhanced efficacy for patients seeking weight management solutions. The nationwide availability of Wegovy HD signifies an expansion of treatment options for individuals managing obesity. This development is a key step in Novo Nordisk's strategy to address the growing demand for effective weight-loss therapies.